Impact of 5-HT(3) receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study

BACKGROUND: 1(st) generation 5-hydroxytryptamine receptor antagonists (5-HT(3) RAs), and palonosetron, a 2(nd) generation 5-HT(3) RA, are indicated for the prevention of chemotherapy (CT)-induced nausea and vomiting (CINV) associated with moderately (MEC) and highly emetogenic CT agents (HEC). This...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Swu-Jane, Hatoum, Hind T, Buchner, Deborah, Cox, David, Balu, Sanjeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437203/
https://www.ncbi.nlm.nih.gov/pubmed/22823909
http://dx.doi.org/10.1186/1472-6963-12-215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437203/
https://www.ncbi.nlm.nih.gov/pubmed/22823909
http://dx.doi.org/10.1186/1472-6963-12-215

Ejemplares similares